Albert Labs International Corp. (ABRT.CN)
- Previous Close
0.0050 - Open
0.0000 - Bid --
- Ask 0.0150 x --
- Day's Range
0.0050 - 0.0050 - 52 Week Range
0.0050 - 0.0350 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
372,066 - Beta (5Y Monthly) 2.78
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada.
albertlabs.comRecent News: ABRT.CN
View MorePerformance Overview: ABRT.CN
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ABRT.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ABRT.CN
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-425.88%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.31M
Diluted EPS (ttm)
-0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
111
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.53M